Open AccessEffects of Lipid‐Lowering and Antihypertensive Treatments in Addition to Healthy Lifestyles in Primary Prevention: An Analysis of the HOPE‐3 Trial
Author(s) -
Dagenais Gilles R.,
Jung Hyejung,
Lonn Eva,
Bogaty Peter M.,
Dehghan Mahshid,
Held Claes,
Avezum Alvaro,
Jansky Petr,
Keltai Matyàs,
Leiter Lawrence A.,
LopezJaramillo Patricio,
Toff William D.,
Bosch Jackie,
Yusuf Salim
Publication year - 2018
Publication title -
journal of the american heart association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.494
H-Index - 85
ISSN - 2047-9980
DOI - 10.1161/jaha.118.008918
Subject(s) - medicine , primary prevention , pharmacology , physical therapy , traditional medicine , disease
It is not clear whether the effects of lipid-lowering or antihypertensive medications are influenced by adherence to healthy lifestyle factors. We assessed the effects of both drug interventions in subgroups by the number of healthy lifestyle factors in participants in the HOPE-3 (Heart Outcomes Prevention Evaluation) trial.